Triple therapy shows promise for tough liver cancers
NCT ID NCT07230080
First seen Nov 17, 2025 · Last updated May 21, 2026 · Updated 22 times
Summary
This study looked at 17 adults with intermediate to advanced liver cancer that could not be removed by surgery. They received a sequence of three treatments: a procedure to block the tumor's blood supply (TACE), precise radiation (SBRT), and drugs that help the immune system attack the cancer. The goal was to see if this combination could shrink tumors and control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nanfang Hosptial
Guangzhou, China
Conditions
Explore the condition pages connected to this study.